Amended Report of Foreign Issuer (6-k/a)
January 06 2020 - 10:56AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 6-K/A
Amendment No. 1
REPORT OF FOREIGN
PRIVATE ISSUER
PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES
EXCHANGE ACT OF 1934
For the month of
December 2019
Commission File
Number 333-209744
TODOS MEDICAL
LTD.
(Translation of
registrant's name into English)
1 Hamada Street
Rehovot, Israel
2244427
Tel: (011) (972)
8-633-3964
(Address of Principal
Executive Offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
☒ Form 20-F ☐ Form
40-F
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
EXPLANATORY NOTE
This Amendment No. 1 on Form 6-K/A
amends the Report of Foreign Issuer on Form 6-K of Todos Medical Ltd. dated January 3, 2020 and filed with the Securities
and Exchange Commission on January 3, 2020 (the “Original Filing”). This Amendment No. 1 is being provided
solely to add disclosure that Mr. Rami Zigdon shall continue to act as Chief Business Officer of Todos Medical Ltd. and Mr. Ben
Naim shall remain as an accounting consultant. No other changes have been made to the Original Filing.
Departure of Directors or Principal
Officers; Election of Directors; Appointment of Principal Officers
Resignation of David Ben Naim
On December 30, 2019, Mr. David Ben
Naim, the Company’s Chief Financial Officer, resigned from his position as CFO of the Company for personal reasons. Mr. Ben
Naim’s resignation was not the result of any disagreement with the Company relating to the Company’s operations, policies,
or practices. Mr. Ben Naim will remain as an accounting consultant to the Company.
Resignation of Directors
On December 30, 2019, Mr. Rami Zigdon
resigned from the Board of Directors of the Company for personal reasons. Mr. Zigdon remains as the Company’s Chief Business
Officer. Mr. Zigdon did not serve on any committees of the Board of Directors. The resignation was not the result of any disagreement
with the Company relating to the Company’s operations, policies, or practices.
On December 31, 2019, Mr. Alon Shalev
and Ms. Ronit Even-Zahav Meitin, the Company’s external directors, resigned from the Board of Directors of the Company due
to the fact that the Company has not paid its external directors, and due to the CFO's resignation the day before. Mr. Shalev and
Ms. Even-Zahav Meitin served on the Audit Committee and on the Compensation Committee of the Board of Directors. The resignations
were not the result of any disagreement with the Company relating to the Company’s operations, policies, or practices.
Signatures
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
TODOS MEDICAL LTD.
|
|
|
|
|
By:
|
/s/ Gerald Commissiong
|
|
|
Name: Gerald Commissiong
|
|
|
Title: Chief Executive Officer
|
|
|
|
Date: January 6, 2020
|
|
|
-2-
Todos Med (CE) (USOTC:TOMDF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Todos Med (CE) (USOTC:TOMDF)
Historical Stock Chart
From Apr 2023 to Apr 2024